NHS England reprimanded over Palantir data access omission
NHS gave Palantir 'unlimited access' to identifiable patient data without disclosing it to the public regulator.
Why it matters
A major healthcare institution's opaque deployment of AI/data analytics infrastructure raises governance, privacy, and public-trust questions — the kind of regulatory and reputational risk that shapes how enterprises approach AI in sensitive sectors.
The key facts
10 to knowNHS England reprimanded by regulator over Palantir data access
Palantir staff given 'unlimited access' to identifiable patient data
Access omitted from public disclosure
Date: July 28, 2026
Source: Financial Times
Regulatory action (reprimand) indicates governance failure, not just vendor behavior
NHS England reprimanded for omitting this access from public disclosure
Raises questions about AI/data platform governance in healthcare
Relevant to regulated industry deployments and data governance
Highlights transparency gap in AI infrastructure adoption
Go to the source
Financial Times Technologyft.com
Publisher excerpt: Staff from controversial tech company have been given ‘unlimited access’ to identifiable patient data